Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.57%151.53M | 7.00%162.92M | 17.62%147.85M | 55.81%600.75M | 17.00%160.46M | 165.74M | 152.26M | 125.7M | 4.98%385.56M | 28.81%137.15M |
| Cost of revenue | -11.50%129.96M | 6.26%136.89M | 18.76%125.31M | 54.27%517.8M | 22.19%140.04M | 146.84M | 128.82M | 105.52M | 2.72%335.64M | 19.29%114.6M |
| Gross profit | 14.12%21.57M | 11.05%26.03M | 11.69%22.54M | 66.16%82.95M | -9.41%20.42M | 18.9M | 23.44M | 20.18M | 23.17%49.92M | 116.72%22.55M |
| Operating expense | -77.94%4.44M | 156.68%7.32M | 83.15%5.13M | 75.19%21.18M | -6.04%7.01M | 20.11M | 2.85M | 2.8M | 9.58%12.09M | 52.19%7.47M |
| Selling and administrative expenses | -77.94%4.44M | 156.68%7.32M | 83.15%5.13M | 76.07%21.7M | -9.42%7.01M | --20.11M | --2.85M | --2.8M | 10.33%12.32M | 53.60%7.74M |
| -Selling and marketing expense | 31.07%59.94K | -10.56%79.39K | -45.85%29.57K | -17.69%302.51K | 952.71%121.4K | --45.73K | --88.77K | --54.61K | 108.58%367.53K | -77.29%11.53K |
| -General and administrative expense | -78.19%4.38M | 162.06%7.24M | 85.72%5.1M | 78.96%21.39M | -10.85%6.89M | --20.06M | --2.76M | --2.75M | 8.76%11.95M | 54.93%7.73M |
| Total other operating income | ---- | ---- | ---- | 122.00%517.39K | ---- | ---- | ---- | ---- | 71.52%233.05K | ---- |
| Operating profit | 1,522.03%17.14M | -9.11%18.71M | 0.17%17.41M | 63.27%61.77M | -11.08%13.41M | -1.21M | 20.59M | 17.38M | 28.26%37.83M | 174.30%15.08M |
| Net non-operating interest income (expenses) | -85.08%221.87K | -39.99%660.29K | -42.56%405.95K | 150.00%4.04M | 180.18%745.63K | 1.49M | 1.1M | 706.69K | 144.64%1.62M | -19.61%-929.97K |
| Non-operating interest income | -86.42%223.19K | -47.95%661.76K | -54.75%450.79K | 45.29%4.74M | 238.27%828.97K | --1.64M | --1.27M | --996.26K | 1,074.98%3.26M | --245.06K |
| Non-operating interest expense | -99.16%1.32K | -99.14%1.47K | -84.52%44.84K | -54.39%700.63K | -91.80%83.34K | --156.7K | --171.02K | --289.57K | -60.59%1.54M | -3.72%1.02M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --110.56K | ---- |
| Net investment income | -49.38%2.89M | 24,228.73%5.71M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 690.77%763.54K | 702.29%1.01M | 167.96%1.43M | 413.41K | 96.56K | 125.96K | 533.35K | ||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -98.05%1.5K | 1,882.17%76.93K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | 98.05%-1.5K | ---- | ---- | ---- | ---- | -1,882.17%-76.93K | ---- |
| Other non-operating income (expenses) | 1,278.81%3.62M | 222.25%636.76K | -29.17%1.98M | 1,032.14%93.06K | 12.83M | 262.39K | -520.86K | 2.8M | 8.22K | |
| Income before tax | 2,090.14%20.98M | -2.31%20.77M | -0.97%20.81M | 53.40%70.23M | 92.19%26.99M | 957.73K | 21.26M | 21.02M | 76.72%45.78M | 211.45%14.04M |
| Income tax | 2,660.66%4.89M | -15.70%4.41M | -10.81%4.72M | 22.24%9.21M | -226.85%-1.48M | 177.16K | 5.23M | 5.29M | 94.55%7.53M | 291.73%1.17M |
| Net income | 1,960.65%16.08M | 2.05%16.36M | 2.34%16.1M | 59.53%61.02M | 121.18%28.47M | 780.57K | 16.03M | 15.73M | 73.59%38.25M | 151.48%12.87M |
| Net income continuous operations | 1,960.65%16.08M | 2.05%16.36M | 2.34%16.1M | 59.53%61.02M | 121.18%28.47M | --780.57K | --16.03M | --15.73M | 73.59%38.25M | 151.48%12.87M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 1,960.65%16.08M | 2.05%16.36M | 2.34%16.1M | 59.53%61.02M | 121.18%28.47M | 780.57K | 16.03M | 15.73M | 73.59%38.25M | 151.48%12.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1,960.65%16.08M | 2.05%16.36M | 2.34%16.1M | 59.53%61.02M | 121.18%28.47M | 780.57K | 16.03M | 15.73M | 73.59%38.25M | 151.48%12.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 1,966.67%0.0124 | -6.67%0.0126 | -7.25%0.0124 | 51.23%0.049 | 90.56%0.0229 | 0.0006 | 0.0135 | 0.0133 | 28.40%0.0324 | 151.89%0.012 |
| Diluted earnings per share | 1,966.67%0.0124 | -6.67%0.0126 | -7.02%0.0124 | 51.13%0.049 | 90.28%0.0228 | 0.0006 | 0.0135 | 0.0133 | 28.40%0.0324 | 151.89%0.012 |
| Dividend per share | 0.0085 | 33.33%0.012 | 16.01%0.0097 | 0.0277 | 0.0103 | 0 | 0.009 | 0.0083 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.